Evidence map›Paper›PMID 20970476›Full record

ArticleNeuroscience letters2011

Calcineurin inhibition with systemic FK506 treatment increases dendritic branching and dendritic spine density in healthy adult mouse brain.

Tara L Spires-Jones, Kevin Kay, Roland Matsouka, Anete Rozkalne, Rebecca A Betensky, Bradley T Hyman

Abstract read
In one paragraph

Article in Neuroscience letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Cause or compensation?-Altered neuronal CaCNS neuroscience & therapeutics · 2018
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tara L Spires-JonesMassachusetts General Hospital/Harvard Medical School, MassGeneral Institute for Neurodegenerative Diseases, 114 16th Street, Charlestown, MA 02129, USA.
Kevin Kay
Roland Matsouka
Anete Rozkalne
Rebecca A Betensky
Bradley T Hyman

Funding

THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1985 to 2018
$42.1M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Teresa Gomez-Isla · 2019 to 2026
$36.5M
NEUROPATHOLOGICAL ALTERATIONS IN ALZHEIMERS DISEASER01AG008487 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1995 to 2010
$5.4M
Calcineurin-mediated neurodegeneration in Alzheimer DiseaseR01AG041507 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 2011 to 2015
$2.0M
Synaptic loss and plasticity in aging and Alzheimer's diseaseK99AG033670 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI SPIRES-JONES, TARA LEIGH · 2009 to 2010
$177k
PATHOLOGICAL ALTERATIONS IN ALZHEIMER'S DISEASER29AG008487 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T · 1989 to 1993
–
NIA NIH HHS AG08487NIA NIH HHS K99 AG033670NIA NIH HHS K99 AG033670-01A1NIA NIH HHS P30 AG062421NIA NIH HHS P50 AG005134NIA NIH HHS R01 AG008487NIA NIH HHS R01 AG041507
6 · The paper itself

Abstract

Calcineurin has been implicated as part of a critical signaling pathway for learning and memory, and recent data suggest that calcineurin activation mediates some of the neurotoxicity of the Alzheimer related neurotoxin Aβ. Immunosuppression via calcineurin inhibition with the compound FK506 is an important treatment for organ transplant patients. Here we use Golgi impregnation techniques, along with a new survival analysis-based statistical approach for analysis of dendritic complexity, to show that in healthy adult mice one week of treatment with FK506 affects both the branching patterns and dendritic spine density of cortical neurons. These results indicate that calcineurin inhibition leads to readily detectable changes in brain morphology, further implicating calcineurin related pathways in both the function and structure of the adult brain.

Indexed as

Calcineurin InhibitorsAnimalsBrainDendritic SpinesImmunosuppressive AgentsMiceTacrolimusCalcineurin InhibitorsImmunosuppressive AgentsTacrolimus

Identifiers

PMID20970476
PMCPMC3010509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.